# Fibromyalgia Study In Adults

> **NCT00256893** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 164 (—)

## Conditions studied

- Fibromyalgia Syndrome, Primary

## Interventions

- **DRUG:** ropinirole

## Key facts

- **NCT ID:** NCT00256893
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 164 (—)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256893, "Fibromyalgia Study In Adults". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00256893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*